Christi Shaw's Net Worth
$5.86 Million
Who is Christi Shaw?
Christi Shaw has an estimated net worth of $5.86 Million. This is based on reported shares across multiple companies, which include Avantor, Inc., LILLY ELI & CO, and Beam Therapeutics Inc..
SEC CIK
Christi Shaw's CIK is 0001702473
Past Insider Trading and Trends
2019 was Christi Shaw's most active year for acquiring shares with 2 total transactions. Christi Shaw's most active month to acquire stocks was the month of April. 2019 was Christi Shaw's most active year for disposing of shares, totalling 5 transactions. Christi Shaw's most active month to dispose stocks was the month of April. 2023 saw Christi Shaw paying a total of $0.00 for 48,854 shares, this is the most they've acquired in one year. In 2019 Christi Shaw cashed out on 34,577 shares for a total of $2,438,633.24, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Avantor, Inc. (AVTR) Snapshot price: $23.68
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +37.06% | 9.81K |
—
|
—
| 36.27K |
May 11
| |||
Form 4
| +33.85% | 6.69K |
—
|
—
| 26.46K |
May 12
| |||
Form 4
| +6.55% | 1.22K |
—
|
—
| 19.77K |
Apr 1
| |||
Form 4
| +63.93% | 7.24K |
—
|
—
| 18.55K |
Feb 25
| |||
Form 4
| -55.79% | -14.29K |
$26.68 | -$381,150.48 | 11.32K |
Dec 11
| |||
Form 4
| +79.23% | 11.32K |
—
|
—
| 25.61K |
Feb 21
| |||
Form 4
|
∞
| 14.29K |
—
|
—
| 14.29K |
May 21
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
LILLY ELI & CO (LLY) Snapshot price: $728.335
SVP and Pres., Lilly Bio-Meds
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4/A
| -93.40% | -7.08K |
$117.08 | -$828,575.16 | 500 |
Scheduled
|
May 3
| ||
Form 4
| -100.00% | -7.58K |
$117.14 | -$887,570.16 |
0
|
Scheduled
|
May 3
| ||
Form 4
|
∞
| 7.58K |
$117.04 | -$722,487.92 | 7.58K |
May 1
| |||
Form 4/A
| -100.00% | -8.43K |
$82.10 | -$691,774.60 |
0
|
Scheduled
|
May 29
| ||
Form 4
| -100.00% | -8.43K |
$82.10 | -$691,774.60 |
0
|
May 29
| |||
Form 4
|
∞
| 8.43K |
$81.07 | -$431,616.68 | 8.43K |
May 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 1
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Beam Therapeutics Inc. (BEAM) Snapshot price: $27.68
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 5
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 13
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||